Protective effects of HGF-MSP chimer (metron factor-1) on liver ischemia-reperfusion injury in rat model

OBJECTIVE: It has been reported that metron factor‐1 (MF‐1), an engineered chimerical factor containing selected functional domains of hepatocyte growth factor and macrophage‐stimulating protein (HGF–MSP), could prevent apoptosis and have an anti‐inflammatory effect. In this study, we investigate the protective effect of MF‐1 on liver ischemia‐reperfusion (I/R) injury. METHODS: Overall 30 Sprague Dawley rats were randomly divided into three groups: the I/R model group (n = 12), the MF‐1 treatment group (n = 12), and the sham‐operated group (n = 6). Liver I/R injury was induced by clamping the blood supply to the left and median lobes of liver by an atraumatic clamp for 90 min, then removing the clamp and allowing reperfusion. Blood samples were obtained on days 1, 2, 3 and 7 to assess liver biochemistry and the histology of liver tissue. Levels of malondialdehyde (MDA), superoxide dismutase (SOD), nitric oxide (NO), endothelial nitric oxide synthase and inducible nitric oxide synthase were measured. In addition, the anti‐oxidative effect of MF‐1 on hepatocytes was assessed in vitro. RESULTS: MF‐1 treatment improved the rat survival rate significantly (P